Has Heather Wells-Holtey, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,848 in general payments to Heather Wells-Holtey, MD across 89 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Heather Wells-Holtey, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Heather Wells-Holtey, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Heather Wells-Holtey, MD

Dermatology · Milwaukee, WINPI 1447320403

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $842, 2.6 times the $321 reported in 2019.

$2,848in general payments, 2019–2025

Across 89 payments — averaging $32.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

E.r. Squibb & Sons, L.L.C.$575
AbbVie$374
Sun Pharmaceutical Industries Inc.$326
Pfizer$230
Sanofi$227
LEO Pharma Inc.$188
plus $927 from 17 others

What the payments were for

Food & beverage$2,848100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	5	$575
AbbVie	24	$374
Sun Pharmaceutical Industries Inc.	4	$326
Pfizer	6	$230
Sanofi	8	$227
LEO Pharma Inc.	6	$188
Incyte Corporation	4	$146
Novartis	5	$110
Bristol Myers Squibb	2	$108
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$84
Johnson & Johnson	3	$73
Stemline Therapeutics Inc.	1	$57
Amgen	2	$50
UCB, Inc.	2	$49
Prugen, Inc. Pharmaceuticals	4	$44
Galderma Laboratories, L.p.	2	$39
Lilly USA, LLC	2	$30
Verrica Pharmaceuticals Inc.	1	$30
Boehringer Ingelheim	1	$26
Taro Pharmaceuticals USA, Inc.	1	$22
Regeneron Healthcare Solutions, Inc.	1	$20
Organon	2	$20
Dermavant Sciences, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ILUMYA$274
Sotyktu$269
Leqselvi$128

How this compares

$2,848 in reported general payments places this provider in the 80th percentile of 260 dermatology providers in Wisconsin.

See all dermatology providers in Wisconsin →

Medicare billing

Part B allowed, 2024

$100,602

Medicare patients

409

Services billed

1,717

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent SyringeDupilumab	12	$43,588
Metronidazole	116	$8,060
Fluorouracil	62	$4,428
Doxycycline Monohydrate	95	$2,668
Tacrolimus	17	$2,398
Betamethasone Dipropionate	33	$1,898
Clobetasol Propionate	47	$1,624
Triamcinolone Acetonide	135	$1,264
CiclopiroxCiclopirox Olamine	63	$1,251
ValacyclovirValacyclovir Hcl	32	$891
Minocycline Hcl	11	$815
Ketoconazole	38	$794
Minoxidil	105	$731
Hydrocortisone	114	$667
Doxycycline Hyclate	22	$549

Paid to pharmacies, not to this prescriber.

Other dermatology in Milwaukee

Ashley DietrichMilwaukee$466K
Sam HwangMilwaukee$32K
Erik AlexanderMilwaukee$25K
David NelsenJanesville$1.1M
Gabriela MaloneyOconomowoc$725K
Kenneth GordonWauwatosa$577K
Martin OkunFort Atkinson$232K
Betsy WernliManitowoc$177K
Daniel OpelSheboygan$118K
Stephen LewellisPlover$73K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →